Carboplatin-Etoposide Versus Topotecan as Second-Line Treatment for Sensitive Relapsed Small-Cell Lung Cancer: Phase 3 Trial

被引：6
|
作者：
Baize, N. [1 ]
Monnet, I. [2 ]
Greillier, L. [3 ]
Geier, M. [4 ]
Lena, H. [5 ]
Janicot, H. [6 ]
Vergnenegre, A. [7 ]
Crequit, J. [8 ]
Lamy, R. [9 ]
Auliac, J. B. [10 ]
Le Treut, J. [11 ]
Le Caer, H. [12 ]
Gervais, R. [13 ]
Dansin, E. [14 ]
Madroszyk, A. [15 ]
Renault, P. [16 ]
Legarff, G. [17 ]
Schott, R. [18 ]
Saulnier, P. [1 ]
Chouaid, C. [2 ]
机构：
[1] CHU Angers, Angers, France
[2] Chi Creteil, Pneumol, Creteil, France
[3] Ap Marseille, Serv Oncol Multidisciplinaire & Innovat Therapeut, Marseille, France
[4] CHU Brest, Inst Cancerol & Hematol, Brest, France
[5] CHU Rennes, Serv Pneumol, Rennes, France
[6] Hop Montpied, CHU, Clermont Ferrand, France
[7] CHU Limoges, Limoges, France
[8] Ch Beauvais, Beauvais, France
[9] Ch Bretagen Sud, Lorient, France
[10] Ctr Hosp F Quesnay, Mantes La Jolie, France
[11] Ctr Hosp Pays Aix, Aix En Provence, France
[12] Ctr Hosp St Brieuc, St Brieuc, France
[13] Ctr Francois Baclesse, Caen, France
[14] Ctr Oscar Lambret, Lille, France
[15] Inst Paoli Calmette, Marseille, France
[16] Ch Pau, Pau, France
[17] Ctr Hosp St Brieux, St Brieux, France
[18] Clcc Paul Strauss, Strasbourg, France
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期
关键词：
Small Cell Lun Cancer; second line; phase; 3; trial;
D O I：
10.1016/j.jtho.2019.08.490
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OA15.02
引用
收藏
页码：S246 / S246
页数：1
相关论文
共 50 条
  • [41] Multi-institutional phase II trial of irinotecan, cisplatin, and etoposide for sensitive relapsed small-cell lung cancer
    K Goto
    I Sekine
    Y Nishiwaki
    R Kakinuma
    K Kubota
    T Matsumoto
    H Ohmatsu
    S Niho
    T Kodama
    T Shinkai
    T Tamura
    Y Ohe
    H Kunitoh
    N Yamamoto
    H Nokihara
    K Yoshida
    T Sugiura
    K Matsui
    N Saijo
    British Journal of Cancer, 2004, 91 : 659 - 665
  • [42] Multi-institutional phase II trial of irinotecan, cisplatin, and etoposide for sensitive relapsed small-cell lung cancer
    Goto, K
    Sekine, I
    Nishiwaki, Y
    Kakinuma, R
    Kubota, K
    Matsumoto, T
    Ohmatsu, H
    Niho, S
    Kodama, T
    Shinkai, T
    Tamura, T
    Ohe, Y
    Kunitoh, H
    Yamamoto, N
    Nokihara, H
    Yoshida, K
    Sugiura, T
    Matsui, K
    Saijo, N
    BRITISH JOURNAL OF CANCER, 2004, 91 (04) : 659 - 665
  • [43] CARBOPLATIN ETOPOSIDE IN SMALL-CELL LUNG-CANCER
    BISHOP, JF
    ARIYOSHI
    KUNITO
    JOHNSON, DH
    ONCOLOGY, 1992, 49 : 11 - 18
  • [44] Second-line chemotherapy for relapsed small cell lung cancer
    Ebi, N
    Kubota, K
    Nishiwaki, Y
    Hojo, F
    Matsumoto, T
    Kakinuma, R
    Ohmatsu, H
    Sekine, I
    Yokosaki, M
    Gotoh, K
    Yamamoto, H
    Kodama, T
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1997, 27 (03) : 166 - 169
  • [45] A phase II study of paclitaxel (P) and carboplatin (C) as second-line treatment in patients (PTS) with small-cell lung cancer (SCLC)
    Agelaki, S
    Agelidou, M
    Blazogiannakis, G
    Tsiafaki, X
    Palamidas, T
    Kouroussis, C
    Kakolyris, S
    Malliotakis, C
    Samonis, G
    Georgoulias, V
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S258 - S259
  • [46] Optimal drugs for second-line treatment of patients with small-cell lung cancer
    Rossi, Antonio
    Sacco, Paola Claudia
    Sgambato, Assunta
    Casaluce, Francesca
    Santabarbara, Giuseppe
    Palazzolo, Giovanni
    Maione, Paolo
    Gridelli, Cesare
    EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (07) : 969 - 976
  • [47] Combined Chemotherapy Versus Topotecan Monotherapy as Second-Line Treatment for Patients with Sensitive Relapsed SCLC
    Zhang, L.
    Liu, X.
    Cheng, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (12) : S1088 - S1088
  • [48] Carboplatin-etoposide in elderly small cell lung cancer (SCLC) patients: A phase II study
    Larive, S
    Bombaron, P
    ANNALS OF ONCOLOGY, 1998, 9 : 105 - 105
  • [49] Indirect treatment comparison of lurbinectedin versus other second-line treatments for small-cell lung cancer
    Hanvesakul, Raj
    Rengarajan, Badri
    Naveh, Navit
    Boccuti, Anne
    Park, Julie E.
    Adeyemi, Adekemi
    Caisip, Clyde
    Jansen, Jeroen P.
    Wilson, Florence R.
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2023, 12 (05)
  • [50] Second-line chemotherapy for small-Cell Lung Cancer (SCLC)
    Kim, Young Hak
    Mishima, Michiaki
    CANCER TREATMENT REVIEWS, 2011, 37 (02) : 143 - 150
12345